Global LVAD Market 2016-2020

  • ID: 3769462
  • Report
  • Region: Global
  • 61 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abiomed
  • Berlin Heart
  • Cardiac Assist
  • Evaheart
  • HeartWare International
  • Jarvik Heart
  • MORE
About the Left Ventricular Assist Device (LVAD) Market

LVADs supplement the pumping of blood by weak hearts. Surgeons implant this mechanical device as a treatment option for severe heart conditions such as acute or chronic deterioration of cardiac functions and heart failure. Surgeons also use the device for BTT, BTR, BTD, and destination therapies.

The analysts forecast the global LVAD market to grow at a CAGR of 13.19% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global LVAD market for 2016-2020. To calculate the market size, we consider revenue generated from the sales of LVADs.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Left Ventricular Assist Device (LVAD) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abiomed
- Berlin Heart
- HeartWare International
- Jarvik Heart
- St. Jude Medical

Other prominent vendors
- Cardiac Assist
- Evaheart
- ReliantHeart
- Sun Medical Technology Research
- Sunshine Heart

Market drivers
- Shortage of heart donors

Market challenges
- Availability of alternative treatments

Market trends
- Increase in M&A

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abiomed
  • Berlin Heart
  • Cardiac Assist
  • Evaheart
  • HeartWare International
  • Jarvik Heart
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Ventricular assist devices: An overview
  • LVAD
PART 06: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 07: Market segmentation by application

PART 08: Cost analysis of LVAD implantation

PART 09: Geographical segmentation
  • LVAD market in Americas
  • LVAD market in EMEA
  • LVADs market in APAC
PART 10: Market drivers
  • Rise in incidence of CVDs
  • Shortage of heart donors
  • Focus on unmet needs for advanced heart failure
  • Favorable reimbursement policies
PART 11: Impact of drivers

PART 12: Market challenges
  • Availability of alternative treatments
  • Complications related to regulatory compliance
  • Product recalls
  • Complications associated with LVADs
PART 13: Impact of drivers and challenges

PART 14: Market trends
  • Advances in technology
  • Increase in M&A
  • Focus on evidence-based research
PART 15: Vendor landscape
  • Competitive scenario
  • Market share analysis
  • Key vendor analysis
  • Abiomed
  • Berlin Heart
  • HeartWare International
  • Jarvik Heart
  • St. Jude Medical
  • Other prominent vendors
PART 16: Appendix
  • List of abbreviations
PART 17: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Market share of LVAD in ventriculat assist device in 2015
Exhibit 03: Market share of LVAD in ventriculat assist device in 2020
Exhibit 04: Number of LVADS implanted 2006-2011
Exhibit 05: Global LVADs market 2015-2020 ($ millions)
Exhibit 06: Five forces analysis
Exhibit 07: Segmentation of global LVADs market by application
Exhibit 08: Percentage of LVAD applications 2008-2012
Exhibit 09: Global LVADs market segmentation by application 2015
Exhibit 10: Global LVADs market segmentation by application 2020
Exhibit 11: Global destination therapy market 2015-2020 ($ millions)
Exhibit 12: Revenue of Global BTD therapy in LVAD market 2015-2020 ($ millions)
Exhibit 13: Revenue of Global BTT in LVAD market 2015-2020 ($ millions)
Exhibit 14: Revenue of Global BTR therapy in LVAD market 2015-2020 ($ millions)
Exhibit 15: Segmentation of Global LVADs market by application 2015-2020
Exhibit 16: Segmentation of Global LVADs market by application 2015-2020 ($ millions)
Exhibit 17: Cost comparison of different procedures ($)
Exhibit 18: Cost and clinical outcome weightage of LVAD
Exhibit 19: Cost components associated with LVAD implantation
Exhibit 20: Cost breakdown of LVAD
Exhibit 21: Cost breakdown of heart transplantation
Exhibit 22: Cost breakdown for LVAD implantation
Exhibit 23: Cost breakdown for heart transplantation
Exhibit 24: Global LVAD market segmentation by geography 2015
Exhibit 25: LVAD market in Americas 2015-2020 ($ millions)
Exhibit 26: LVAD market in EMEA 2015-2020 ($ millions)
Exhibit 27: LVADs market in APAC 2015-2020 ($ millions)
Exhibit 28: Global LVAD market segmentation by geography 2015-2020 ($ millions)
Exhibit 29: Global LVAD market segmentation by geography 2015-2020
Exhibit 30: Impact of drivers
Exhibit 31: Impact of drivers and challenges
Exhibit 32: Market share of major vendors in left ventricular assist device market in 2015
Exhibit 33: Top vendors in global LVAD market 2015
Exhibit 34: Product portfolio matrix
Exhibit 35: Abiomed: Key takeaways
Exhibit 36: Berlin Heart: Product portfolio
Exhibit 37: Berlin Heart: Key takeaways
Exhibit 38: HeartWare International: Key takeaways
Exhibit 39: Jarvik Heart: Product portfolio
Exhibit 40: Jarvik Heart: Key takeaways
Exhibit 41: St. Jude Medical: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abiomed
  • Berlin Heart
  • Cardiac Assist
  • Evaheart
  • HeartWare International
  • Jarvik Heart
  • MORE
New Report Released: - Global Left Ventricular Assist Device (LVAD) Market 2016-2020

The author of the report recognizes the following companies as the key players in the global left ventricular assist device (LVAD) market: Abiomed, Berlin Heart, HeartWare International, Jarvik Heart, and St. Jude Medical.

Other Prominent Vendors in the market are: Cardiac Assist, Evaheart, ReliantHeart, Sun Medical Technology Research, and Sunshine Heart.

Commenting on the report, an analyst from the research team said: “A trend that is sure to boost market growth is the increase in M&A. Vendors undergo M&A to extend their product offerings, increase their market share, and expand their operations. They acquire other companies to enhance their R&D capabilities for manufacturing innovative devices that can meet consumer needs. Acquisition of other companies allows vendors access to the product portfolio of the acquired company. M&A also helps new players enter the market. In 2013, Thoratec acquired the rights to Terumo Heart’s DuraHeart II ventricular assist system. In 2014, Thoratec acquired Apica Cardiovascular to expand its LVAD product portfolio. In October 2015, St. Jude Medical acquired Thoratec for about $3.3 billion. In September 2015, HeartWare International entered into a definitive agreement to acquire Valtech Cardio.”

According to the report, a key growth driver is the shortage of heart donors. CVDs can sometimes lead to severe heart failure. In such cases, it becomes mandatory for people to undergo heart transplantation. However, it is difficult to obtain heart transplants due to the shortage of heart donors. The number of people worldwide that require heart transplantations is rising with each passing year, but there has not been a corresponding rise in heart donors, which is leading to an increase in the average waiting time for heart transplantation. The average waiting time for heart transplantation in the US is 9-11 months. However, in most cases, it goes up to two years. In 2013, the Health Resources and Services Administration estimated that about 18 people die every day in the US due to a shortage of donor hearts.

Further, the report states that one challenge that could impact market growth is the availability of alternative treatments. The presence of alternative treatment options, such as heart transplantation, drug therapy, and TAHs to address acute heart failure and improve cardiac output, hinder the sales of LVADs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Abiomed
- Berlin Heart
- HeartWare International
- Jarvik Heart
- St. Jude Medical
- Cardiac Assist
- Evaheart
- ReliantHeart
- Sun Medical Technology Research
- Sunshine Heart.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll